1 kits (10 Vials)
| samuwa: | |
|---|---|
| Yawan: | |
▎ Tesamoreli
A matsayin analog na haɓakar haɓakar hormone (GHRH), Tesamoreli yana nuna ƙimar asibiti mai mahimmanci a cikin kula da takamaiman cututtuka. Matsakaicin sa na warkewa shine shiga tsakani a cikin ƙarancin tarin kitse na ciki a cikin mutane masu kamuwa da cutar HIV wanda ya haifar da dogon lokaci na maganin rigakafi. Wannan miyagun ƙwayoyi yana kwatanta yanayin aikin kwayoyin halitta na GHRH na ƙarshe, yana ɗaure ga takamaiman masu karɓa akan saman ƙwayoyin hormone girma a cikin glandar pituitary na baya, yana kunna hanyar siginar sunadaran G, sannan kuma yana haifar da sakin pulsatile na hormone girma (GH) daga glandan pituitary na gaba. Tare da ci gaba da haɓakar ƙwayar GH a cikin tsarin jini na jini, tsarin haɗin gwiwar insulin-kamar girma factor-I (IGF-I) a cikin hanta da nama na gefe yana aiki sosai. Wannan maɓalli mai mahimmancin haɓakar haɓakar kuzarin makamashi na cibiyar sadarwa na adipocytes - gami da haɓaka ayyukan enzymes na lipolytic don haɓaka ɓarnawar kitse na visceral da hana maganganun fatty acid synthase don rage yawan kitse - a ƙarshe cimma sake gina rarrabuwar kitse mara kyau da rage nauyin kitse na ciki.
Baya ga tasirin rage kitse akan gabobin da ake niyya, tasirin magunguna na Tesamoreli yana haifar da fa'idodin ilimin kimiya da yawa ta hanyar tsarin tsarin tsarin GH-IGF-I axis: a matakin haɓaka haɓakar abun da ke cikin jiki, yana haɓaka haɓakar amino acid na ƙwayoyin tsoka na skeletal kuma yana kunna tsarin farfadowa na myofiber wanda ke shiga tsakani ko haɓaka haɓakar sel ta hanyar tauraron dan adam. tasiri na tsari akan ƙarfin tsoka. Wannan tasirin yana da alaƙa da alaƙa da haɓakar haɓakar haɓakar furotin da hana rushewar furotin da aka yi sulhu ta hanyar hormone girma; in the field of bone metabolism, this drug has a protective effect on bone mineral density through a dual mechanism of promoting the differentiation and maturation of osteoblasts and inhibiting the activity of osteoclasts, especially providing a potential intervention approach for the prevention of bone loss associated with chronic diseases. Hanyoyin aikin da ke sama suna nuna cewa Tesamoreli ba'a iyakance ga haɓakar tarin kitse na gida ba amma yana cimma tsarin haɗin gwiwar ayyukan ilimin lissafin jiki na tsarin da yawa a cikin jiki ta hanyar ƙaddamar da axis na rayuwa ta endocrine.
▎ Ipamorelin
A matsayin fili na pentapeptide na roba, Ipamorelin, a matsayin wani muhimmin memba na dangin haɓakar hormone na sirri, yana samun daidaitaccen tsari na axis na haɓakar haɓakar hormone girma ta hanyar ƙirar tsarinsa na musamman. Wannan fili yana ɗaure tare da babban kusanci ga mai karɓar mai karɓar sirri na hormone mai girma (GHS-R), yana kunna hanyar siginar ƙasa, yadda ya kamata ya haifar da sakin pulsatile na hormone girma (GH), kuma a lokaci guda yana haɓaka maganganun kwayoyin halitta da haɓakar furotin na insulin-kamar girma factor-1 (IGF-1). Wannan tsarin aiki guda biyu ba wai kawai yana daidaita tsarin metabolism na makamashi ba (ciki har da inganta haɓakar amino acid, haɓaka haɗin furotin, da haɓaka catabolism mai mai) amma kuma yana taka rawa mai kyau na tsari a gyaran nama da haɓaka ta hanyar haɓaka siginar yaɗuwar tantanin halitta.
A cikin nazarin asibiti, Ipamorelin ya nuna tasirin tsarin tsarin da yawa. Tasirinsa akan inganta motsi na gastrointestinal yana bayyana azaman haɓaka ƙimar zubar da ciki. Musamman ma a cikin yanayin bayan aikin gida, ta hanyar haɓaka mitar peristaltic da ƙarancin ƙwayar gastrointestinal sumul tsokoki, yana magance tabarbarewar motsin hanji yadda ya kamata. A cikin filin kula da ciwo, wannan fili yana daidaita fassarar siginar nociceptive ta hanyar tsakiya da na gefe kuma yana nuna tasiri mai mahimmanci akan ciwon visceral marasa kumburi da ciwon somatic. Tsarin aikinsa na iya haɗawa da kunna tsarin peptide na endogenous opioid peptide da kuma daidaita ayyukan tashar ion.
Idan aka kwatanta da na al'ada girma hormone secretagogues, da gagarumin amfani da Ipamorelin ta'allaka ne a cikin high selectivity ga girma hormone saki. Duk da yake yana da tasiri mai tasiri na GH secretion, wannan fili ba shi da wani tasiri mai mahimmanci akan siginar wasu kwayoyin hormones na pituitary-adrenal axis irin su adrenocorticotropic hormone (ACTH) da cortisol, don haka rage haɗarin mummunan halayen da ke haifar da cututtuka na hormonal. Wannan kayan aikin likitanci yana ba shi damar yin daidaitaccen shiga tsakani a cikin maye gurbin jiyya na ƙarancin hormone girma, kuma a lokaci guda yana ba da sabon maƙasudin miyagun ƙwayoyi don bincike kan cututtukan cututtukan cututtukan ƙwayar cuta na gastrointestinal da inganta haɓakar cututtukan cututtuka da shirye-shiryen jiyya.
▎ Takaitawa
1. Girman Hormone Regulation
Tsarin Haɗin kai:
Tesamoreli yana ƙarfafa haɓakar haɓakar hormone girma (GH) daga glandan pituitary na baya ta hanyar kunna mai karɓar hormone mai sakin hormone (GHRH), yayin da Ipamorelin ke haɓaka ƙwayar ƙwayar ƙwayar cuta ta GH ta hanyar zaɓin kunna mai karɓar mai karɓar sirri na hormone girma (GHSR).
Lokacin da aka yi amfani da su a hade, su biyun na iya haɓaka ɓoyewar GH daga hanyoyi daban-daban, suna haifar da tasiri mai tasiri kuma don haka yana ƙara yawan matakin GH a cikin jiki.
Ma'auni da Kula da Sirrin GH:
Ipamorelin yana guje wa haɗarin haɓakar GH mai wuce kima ta hanyar yin koyi da tsarin siginar ɓarna na halitta na GH, yayin da Tesamoreli yana ba da tabbataccen tushe don ɓoyewar GH ta hanyar GHRH. Wannan haɗin gwiwar amfani zai iya kula da matakin GH yayin tabbatar da rhythmicity da ma'auni na ɓoyewarsa.
2. Gyaran Halittu
Lipid Metabolism:
Tesamoreli yana rage kitse mai visceral ta hanyar haɓaka faɗuwar kitse da haɓaka haɓakar lipid metabolism, yayin da Ipamorelin ya ƙara haɓaka haɓakar mai ta hanyar haɓaka iskar oxygen mai kitse. Lokacin amfani da su a hade, su biyun na iya haɓaka metabolism na lipid tare, rage yawan kitse masu alaƙa da shekaru, da haɓaka haɓakar insulin.
Metabolism na glucose:
Tesamoreli yana rage haɗarin rikice-rikice na rayuwa ta hanyar inganta ingantaccen amfani da glucose, yayin da Ipamorelin ke kare ƙwayar tsoka kuma yana guje wa asarar makamashi ta hanyar tasirin anti-catabolic.
Wannan tasirin synergistic yana taimakawa kiyaye ma'auni na rayuwa kuma yana tallafawa tsufa lafiya.
3. Tallafin Nama da Gyara
Haɗin Protein da Sabunta Tantanin halitta:
Tesamoreli yana inganta gyaran gyare-gyaren nama da farfadowa ta hanyar ƙarfafa haɗin gwiwar furotin da sabuntawar tantanin halitta, yayin da Ipamorelin ya hana rushewar tsoka ta hanyar kare tsarin nama na yanzu. Lokacin da aka yi amfani da su a hade, su biyun na iya ba da cikakkiyar goyon baya na nama, duka suna inganta gyaran gyare-gyaren da suka lalace da kuma kare ƙwayoyin da ke ciki daga lalacewa.
Tasirin hana tsufa:
Haɓakawa a matakin GH yana da alaƙa da alaƙa da tasirin tsufa. Haɗuwa da amfani da Tesamoreli da Ipamorelin na iya jinkirta tsufa na tantanin halitta, inganta elasticity na fata, rage wrinkles, da tallafawa lafiyar kashi.
4. Anti-tsufa da Fahimta
Kariyar Neuro da Ayyukan Fahimi:
GH yana taka muhimmiyar rawa a aikin kwakwalwa da neuroprotection. Haɗuwa da amfani da waɗannan peptides guda biyu na iya inganta aikin fahimi kuma rage raguwar fahimi da ke da alaƙa da shekaru ta hanyar daidaita matakin GH.
Juriyar Tsari:
Ta hanyar daidaita siginar GH da inganta haɓakar metabolism, haɗin haɗin gwiwa zai iya haɓaka tsarin tsarin jiki da kuma tallafawa lafiyar dogon lokaci da ƙarfin aiki.
Game da Marubuci
Abubuwan da aka ambata a sama duk bincike ne, gyara su kuma Cocer Peptides ne suka haɗa su.
DUKKANIN LABARI DA BAYANIN KYAUTATAWA DA AKE BAYAR A WANNAN SHAFIN KAWAI DOMIN WATSA BAYANI NE DA MANUFOFIN ILIMI.
Kayayyakin da aka bayar akan wannan gidan yanar gizon an yi niyya ne kawai don binciken in vitro. Binciken in vitro (Latin: *a cikin gilashi*, ma'ana a cikin gilashin gilashi) ana gudanar da shi a wajen jikin mutum. Waɗannan samfuran ba magunguna ba ne, Hukumar Abinci da Magunguna ta Amurka (FDA) ba ta amince da su ba, kuma dole ne a yi amfani da su don hanawa, magani, ko warkar da duk wani yanayi na likita, cuta, ko cuta. Doka ta haramta shigar da waɗannan samfuran cikin jikin mutum ko dabba ta kowace hanya.